Abstract
Inherited mutations in BRCA1 predispose to breast and ovarian cancer, but the role of BRCA1 in sporadic breast and ovarian cancer has previously been elusive. Here, we show that retroviral transfer of the wild-type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested, but not colon or lung cancer cells or fibroblasts. Mutant BRCA1 has no effect on growth of breast cancer cells; ovarian cancer cell growth is not affected by BRCA1 mutations in the 5′ portion of the gene, but is inhibited by 3′ BRCA1 mutations. Development of MCF-7 tumours in nude mice is inhibited when MCF-7 cells are transfected with wild-type, but not mutant, BRCA1. Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hall, J.M. et al. Linkage of early-onset breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Smith, S.A., Easton, D.F., Evans, D.G.R. & Ponder, B.A.J. Allele losses in the region 17q12–q21 in familial breast and ovarian cancer non-randomly involve the wild-type chromosome. Nature Genet. 2, 128–131 (1992).
Cornelius, R.S. et al. High allele loss rates at 17q12–q21 in breast and ovarian tumors from BRCAI-linked families The Breast Cancer Linkage Consortium. Genes Chrom. Cancer. 13, 203–210 (1995).
Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122 (1994).
Merajver, S.D. et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet. 9, 439–443 (1995).
Hosking, L. et al. A somatic BRCA1 mutation in an ovarian tumour. Nature Genet. 9, 343–344 (1995).
Takahashi, H. et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55, 2998–3002 (1995).
Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L. & Holt, J.T. Decreased expression BRCAl accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444–450 (1995).
Friedman, L.S. et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. atureGenet. 8, 399–404 (1994).
Gayther, S.A. et al. Germline mutations of the BRCA1 gene in breast/ovarian cancer families: evidence for a genotype/phenotype correlation. Nature Genet. 11, 428–433 (1995).
Marquis, S.T. et al. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nature Genet. 1, 17–26 (1995).
Lane, T.F. et al. Expression of BRCA1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712–2722 (1995).
Jensen, R.A. et al. BRCA1 is secreted and exhibits properties of a granin. Nature Genet. 12, 303–308 (1996).
Arteaga, C.L. & Holt, J.T. Tissue-targeted c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. Cancer Res. 56, 1098–1103 (1996).
Soule, H.D. & McGrath, C.M. Estrogen responsive proliferation of clonal human breast carcinoma in athymic mice. Cancer Lett. 10, 177–189 (1980).
Jensen, R.A., Beeler, J.F., Heidaran, M.A. & LaRochelle, W.J. Purification and characterization of baculovirus-expressed human α and β platelet-derived growth factor receptors. Biochemistry. 31, 10887–10892 (1992).
Jensen, R.A., Page, D.L. & Holt, J.T. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proc. Natl. Acad. Sci. USA 91, 9257–9261 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holt, J., Thompson, M., Szabo, C. et al. Growth retardation and tumour inhibition by BRCA1. Nat Genet 12, 298–302 (1996). https://doi.org/10.1038/ng0396-298
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0396-298
This article is cited by
-
Retarding breast tumor growth with nanoparticle-facilitated intravenous delivery of BRCA1 and BRCA2 tumor suppressor genes
Scientific Reports (2023)
-
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
Nature Communications (2016)
-
BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function
Oncogene (2015)
-
Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations
Cancer Cell International (2013)
-
A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display
Clinical and Translational Oncology (2013)
